NO169775C - Analogifremgangsmaate for fremstilling av nye oligosaccharider - Google Patents

Analogifremgangsmaate for fremstilling av nye oligosaccharider

Info

Publication number: NO169775C
Authority: NO; Norway
Prior art keywords: preparation; oligosaccharides; ribitol; ribose; phosphate
Prior art date: 1986-12-31

Application number

NO875442A

Other languages

English (en)

Norwegian (no)

Other versions

NO875442D0 (no

NO169775B (no

NO875442L (no

Inventor

Eduard Coen Beuvery

Adolf Evenberg

Jan Theunis Poolman

Jacobus Hubertus Van Boom

Peter Hoogerhout

Constant Adriaan Anton Boeckel

Original Assignee

Rivm Of Bilthoven

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1986-12-31

Filing date

1987-12-28

Publication date

1992-08-05

1987-12-28 Application filed by Rivm Of Bilthoven filed Critical Rivm Of Bilthoven

1987-12-28 Publication of NO875442D0 publication Critical patent/NO875442D0/no

1988-07-01 Publication of NO875442L publication Critical patent/NO875442L/no

1992-04-27 Publication of NO169775B publication Critical patent/NO169775B/no

1992-08-05 Publication of NO169775C publication Critical patent/NO169775C/no

Links

229920001542 oligosaccharide Polymers 0.000 title abstract 4
150000002482 oligosaccharides Chemical class 0.000 title abstract 4
KRBIJIBTUCNJGU-BLADHDKVSA-N OP(O)(O)=O.OC[C@H](O)[C@H](O)[C@H](O)CO.OC[C@@H](O)[C@@H](O)[C@@H](O)C=O Chemical compound OP(O)(O)=O.OC[C@H](O)[C@H](O)[C@H](O)CO.OC[C@@H](O)[C@@H](O)[C@@H](O)C=O KRBIJIBTUCNJGU-BLADHDKVSA-N 0.000 abstract 3
229960005486 vaccine Drugs 0.000 abstract 3
241000606768 Haemophilus influenzae Species 0.000 abstract 1
229940045808 haemophilus influenzae type b Drugs 0.000 abstract 1
208000015181 infectious disease Diseases 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
- C07H21/02—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with ribosyl as saccharide radical
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/02—Acyclic radicals, not substituted by cyclic structures
- C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants

Landscapes

Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Immunology (AREA)
Engineering & Computer Science (AREA)
Molecular Biology (AREA)
Biochemistry (AREA)
Public Health (AREA)
Biotechnology (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Genetics & Genomics (AREA)
Veterinary Medicine (AREA)
Mycology (AREA)
Crystallography & Structural Chemistry (AREA)
Microbiology (AREA)
Epidemiology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Saccharide Compounds (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Peptides Or Proteins (AREA)

NO875442A 1986-12-31 1987-12-28 Analogifremgangsmaate for fremstilling av nye oligosaccharider NO169775C (no)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
NL8603325		1986-12-31

Publications (4)

Publication Number	Publication Date
NO875442D0 NO875442D0 (no)	1987-12-28
NO875442L NO875442L (no)	1988-07-01
NO169775B NO169775B (no)	1992-04-27
NO169775C true NO169775C (no)	1992-08-05

Family

ID=19849078

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO875442A NO169775C (no)	1986-12-31	1987-12-28	Analogifremgangsmaate for fremstilling av nye oligosaccharider

Country Status (15)

Country	Link
US (1)	US5034519A (es)
EP (1)	EP0276516B1 (es)
JP (1)	JPS63190896A (es)
KR (1)	KR880007557A (es)
AT (1)	ATE87003T1 (es)
AU (1)	AU603405B2 (es)
CA (1)	CA1335405C (es)
DE (1)	DE3784907T2 (es)
DK (1)	DK694687A (es)
ES (1)	ES2054657T3 (es)
FI (1)	FI89172C (es)
IE (1)	IE59734B1 (es)
NO (1)	NO169775C (es)
NZ (1)	NZ223009A (es)
PT (1)	PT86484B (es)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0320942A3 (en) *	1987-12-18	1989-10-04	American Cyanamid Company	Novel polysaccharides novel macromolecular conjugates of the polysaccharides
ES2051909T3 (es) *	1988-04-19	1994-07-01	American Cyanamid Co	Vacuna del conjugado de polisacarido-proteina de membrana externa contra la haemophilus influenzae tipo b.
US7118757B1 (en) *	1988-12-19	2006-10-10	Wyeth Holdings Corporation	Meningococcal class 1 outer-membrane protein vaccine
CA2006587C (en) *	1988-12-23	2000-01-18	Robert W. Tolan	Membrane proteins and peptides of haemophilus influenzae type b
GB8924473D0 (en) *	1989-10-31	1989-12-20	Connaught Lab	Outer membrane protein p1 and peptides of haemophilus influenzae b
NZ239643A (en) *	1990-09-17	1996-05-28	North American Vaccine Inc	Vaccine containing bacterial polysaccharide protein conjugate and adjuvant (c-nd-che-a-co-b-r) with a long chain alkyl group.
US5153312A (en) *	1990-09-28	1992-10-06	American Cyanamid Company	Oligosaccharide conjugate vaccines
US5843463A (en) *	1990-12-21	1998-12-01	Antexbiologics, Inc.	Adhesin-oligosaccharide conjugate vaccine for Haemophilus influenzae
CA2098598A1 (en) *	1990-12-21	1992-06-22	Howard C. Krivan	Adhesin-oligosaccharide conjugate vaccine for haemophilus influenzae
CA2059692C (en) *	1991-01-28	2004-11-16	Peter J. Kniskern	Pneumoccoccal polysaccharide conjugate vaccine
CA2059693C (en) *	1991-01-28	2003-08-19	Peter J. Kniskern	Polysaccharide antigens from streptococcus pneumoniae
DE69126522T2 (de) *	1991-05-20	1997-11-06	Kao Corp	Neue Phosphobetain und die enthaltende Detergenz und Cosmetica
US5371197A (en) *	1991-09-24	1994-12-06	Merck & Co., Inc.	Protein-dimeric polysaccharide conjugate vaccine
GB9202219D0 (en) *	1992-02-03	1992-03-18	Connaught Lab	A synthetic heamophilus influenzae conjugate vaccine
PT647140E (pt) *	1992-06-25	2007-12-27	Univ Georgetown	Vacinas de papilomavírus
US7148031B2 (en)	1994-07-26	2006-12-12	The Mitre Corporation	Sequestering of glycoprotein molecules and oligosaccharide moieties in lipo-glycoprotein membranes and micelles
US6032849A (en) *	1995-08-28	2000-03-07	United States Surgical	Surgical stapler
US5782396A (en)	1995-08-28	1998-07-21	United States Surgical Corporation	Surgical stapler
US5762256A (en)	1995-08-28	1998-06-09	United States Surgical Corporation	Surgical stapler
SE9601158D0 (sv) *	1996-03-26	1996-03-26	Stefan Svenson	Method of producing immunogenic products and vaccines
PT939647E (pt) *	1996-08-27	2002-04-29	Chiron Corp	Glicpconjugados do serogrupo b de neisseria meningitidis e metodos de utilizacao dos mesmos
US6267961B1 (en) *	1996-11-22	2001-07-31	Baxter International Inc.	Direct methods for molar-mass determination of fragments of Haemophilus influenzae type b capsular polysaccharides and vaccine preparation
CU22904A1 (es) *	1999-08-30	2004-01-23	Univ De Ottawa	Oligosacáridos derivados de ribosa- ribitol-fosfato, métodos para prepararlos, inmunógenos que los comprenden y vacunas que comprenden dichos inmunógenos
US8785134B2 (en)	2008-11-10	2014-07-22	The Mitre Corporation	Glycoprotein vesicles and their methods of use
MX2019001167A (es)	2016-07-28	2019-09-16	Max Planck Gesellschaft	Derivados sinteticos estables de poliribosilribitolfosfato resistentes a la hidrolisis como vacunas contra haemophilus influenzae tipo b.
CN108776223B (zh) *	2018-04-19	2021-04-06	广州质量监督检测研究院	紫外吸收剂uv-326检测试剂盒及其制备方法和应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4220717A (en) *	1977-12-22	1980-09-02	American Cyanamid Company	Isolation and purification of polyribosyl ribitol phosphate from Haemophilus influenzae type b.
US4264764A (en) *	1979-01-12	1981-04-28	Merck & Co., Inc.	Meningitis vaccine
US4673574A (en) *	1981-08-31	1987-06-16	Anderson Porter W	Immunogenic conjugates
US4451446A (en) *	1982-03-04	1984-05-29	Smithkline-Rit	Process for the preparation of polysaccharide-protein complexes from bacterial capsules, obtained products and immunogenic compositions containing them
US4496538A (en) *	1982-07-06	1985-01-29	Connaught Laboratories, Inc.	Haemophilus influenzae b polysaccharide-diphtheria toxoid conjugate vaccine
US4644059A (en) *	1982-07-06	1987-02-17	Connaught Laboratories, Inc.	Haemophilus influenzae B polysaccharide-diptheria toxoid conjugate vaccine
US4459286A (en) *	1983-01-31	1984-07-10	Merck & Co., Inc.	Coupled H. influenzae type B vaccine

1987
- 1987-12-21 NZ NZ223009A patent/NZ223009A/xx unknown
- 1987-12-22 IE IE351087A patent/IE59734B1/en not_active IP Right Cessation
- 1987-12-28 EP EP87202625A patent/EP0276516B1/en not_active Expired - Lifetime
- 1987-12-28 FI FI875727A patent/FI89172C/fi not_active IP Right Cessation
- 1987-12-28 ES ES87202625T patent/ES2054657T3/es not_active Expired - Lifetime
- 1987-12-28 AT AT87202625T patent/ATE87003T1/de not_active IP Right Cessation
- 1987-12-28 DE DE8787202625T patent/DE3784907T2/de not_active Expired - Fee Related
- 1987-12-28 NO NO875442A patent/NO169775C/no unknown
- 1987-12-29 US US07/139,349 patent/US5034519A/en not_active Expired - Fee Related
- 1987-12-29 JP JP62336798A patent/JPS63190896A/ja active Pending
- 1987-12-30 CA CA000555549A patent/CA1335405C/en not_active Expired - Fee Related
- 1987-12-30 PT PT86484A patent/PT86484B/pt not_active IP Right Cessation
- 1987-12-30 DK DK694687A patent/DK694687A/da not_active Application Discontinuation
- 1987-12-30 AU AU83145/87A patent/AU603405B2/en not_active Ceased
- 1987-12-30 KR KR1019870015760A patent/KR880007557A/ko not_active Ceased

Also Published As

Publication number	Publication date
PT86484B (pt)	1990-11-20
DK694687D0 (da)	1987-12-30
EP0276516A2 (en)	1988-08-03
ES2054657T3 (es)	1994-08-16
FI875727L (fi)	1988-07-01
JPS63190896A (ja)	1988-08-08
EP0276516A3 (en)	1988-08-17
DK694687A (da)	1988-07-01
FI875727A0 (fi)	1987-12-28
NO875442D0 (no)	1987-12-28
NO169775B (no)	1992-04-27
DE3784907D1 (de)	1993-04-22
FI89172C (fi)	1993-08-25
NZ223009A (en)	1990-06-26
KR880007557A (ko)	1988-08-27
DE3784907T2 (de)	1993-06-24
IE59734B1 (en)	1994-03-23
NO875442L (no)	1988-07-01
US5034519A (en)	1991-07-23
EP0276516B1 (en)	1993-03-17
AU603405B2 (en)	1990-11-15
FI89172B (fi)	1993-05-14
IE873510L (en)	1988-06-30
PT86484A (en)	1988-01-01
CA1335405C (en)	1995-04-25
ATE87003T1 (de)	1993-04-15
AU8314587A (en)	1988-07-07

Similar Documents

Publication	Publication Date	Title
NO875442D0 (no)	1987-12-28	Nye oligosaccharider, immunogener og vaksiner og fremgangsmaater ved fremstilling derav.
LU91610I2 (fr)	2009-11-24	Protéine D et ses dérivés pharmaceutiquement acceptables (SYNFLORIX - Vaccin pneumococcique polysaccharidique conjugé (adsorbé)
FR2499412B1 (fr)	1985-10-04	Production de vaccin antivirus
FI901530A0 (fi)	1990-03-27	Menetelmä immunomoduloivien atsaspiraanien valmistamiseksi
FI882369A7 (fi)	1988-05-19	Menetelmä lääkeaineena käyttökelpoisten piperidiinijohdannaisten valmistamiseksi
FI871041A0 (fi)	1987-03-10	Menetelmä terapeuttisesti käyttökelpoisten 3,5-disubstituoitujen pyrokatekolijohdannaisten valmistamiseksi
ES520259A0 (es)	1984-04-01	Un procedimiento para preparar un complejo inmunogeno no covalentes de polisacarido-proteina, y obtenido a partir de capsulas bacterianas.
UA5571A1 (uk)	1994-12-28	СПОСІБ ОДЕРЖАННЯ 2-БРОМ-alРha-ЕРГОКРІПТІНУ АБО ЙОГО КИСЛОТНО-АДІТИВНИХ СОЛЕЙ
DK0495896T3 (da)	1994-10-10	Vaccine til beskyttelse mod HIV-virusinfektioner, fremgangsmåde til fremstilling heraf og anvendelse heraf som diagnostisk middel og immunterapeutisk middel
NO864147L (no)	1988-04-18	Fremgangsmaate for fremstilling av alginater(polyuronider) med endrede fysikalske egenskaper.
LU80063A1 (fr)	1979-05-15	Procede de preparation d'un vaccin de masse moleculaire elevee contre la meningite a meningocoques du groupe c
ES426215A1 (es)	1976-11-16	Procedimiento para preparar una vacuna de adenovirus bovi- nos vivos.
NO885552D0 (no)	1988-12-14	Nye derivater av cykliske aminosyrer og fremgangsmaate for fremstilling derav.
DK0515415T3 (da)	1995-11-27	Hidtil ukendt vaccine og fremgangsmåde til fremstilling deraf
EP0090660A3 (en)	1983-11-23	Neisseria gonorrhoeae vaccine
PT88420A (pt)	1989-07-31	Process for the preparation of pharmaceutical compositions containing 1-(2'-deoxy-2'-fluoro-beta-d-arabinofuranosyl)-5-ethyluracil and a method for treating hepatitis virus infections by using said compositions
CH541571A (fr)	1973-09-15	Procédé de préparation de nouvelles isopropyl-2 tétrahydrooxazines-1,3 substituées
FI93423C (fi)	1995-04-10	Menetelmä rokotteen valmistamiseksi
IE782146L (en)	1979-04-28	Immunologically active prp.
NO810778L (no)	1981-09-09	Homositronsyre oligoriboside-derivater, fremgangsmaate for deres fremstilling og deres bruk for aa forebygge dental karries
DK42083A (da)	1983-08-04	Fremgangsmaade til fremstilling af et immunogen af pasteurella multocida
PT86745A (pt)	1988-03-01	Process for preparing oxime ethers of 2,6-dioxabicyclo ]3.3.o" octanones
ZA862478B (es)	1986-10-06
DK598184A (da)	1985-06-15	3-aryl-1,2-benzisoxazolsulfonyl- og -sulfinylalkansyrer og farmaceutisk acceptable salte deraf, deres fremstilling og anvendelse som laegemidler
NO882224L (no)	1988-11-23	Fremgangsmaate for fremstilling av analoger av alfa-msh.